Posted by ABMN Staff on Mar 28th, 2024
Assenagon Asset Management S.A. trimmed its stake in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 21.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,945,225 shares...
More of this article »